Capabilities
Businesses adopting artificial intelligence and machine learning technologies and the companies developing them turn to us to navigate regulatory complexities, potential liabilities, and transactional considerations they face on the path to realizing AI’s tremendous potential.
We bring together our extensive technical backgrounds and broad range of subject matter experience to help them:
Our Digital Health lawyers are advising life sciences and healthcare companies as they adopt and develop AI tools and technologies in their businesses and in the products they deliver—from digital diagnostics to digital therapeutic medical devices to medical robotics.
King & Spalding offers deep fintech industry and AI credentials to provide comprehensive legal advice to emerging and established fintech businesses, financial services firms, and PE/VC investors.
Our lawyers are at the forefront of guiding start-ups and emerging growth companies who are developing generative AI platforms and applications and the investors in such technologies.
May 1, 2024
Leveraging NIST: Five Key Approaches to Strengthen AI Governance
April 3, 2024
Federal Enforcers Signal Heightened Scrutiny of Algorithm Use to Inform Pricing Decisions
March 28, 2024
Executive Order Restricts Foreign Access to U.S. Data, Citing National Security Risks
August 10, 2021
Equifax to Acquire Appriss Insights for $1.825 billion
July 15, 2021
HeartFlow To Go Public in SPAC Merger
April 6, 2021
Sidetrade acquires Amalto
Kassi Burns to Speak on the Beverly Hills Bar Association’s Webinar
View all events